Efficacy of Ondansetron on Vomiting Due to Acute Gastroenteritis in Pediatric During Winter (Ondangapi)
Sponsor: Assistance Publique - Hôpitaux de Paris
Terminated
This trial was terminated. No reason was provided.
Other terminated trials from Assistance Publique - Hôpitaux de Paris
- Hepatocellular Carcinoma · Sep 2025
- Memory Consolidation · Phase NA · Aug 2025
- Knee Injuries · Apr 2025
- Metabolic Syndrome · Phase NA · Dec 2024
- Pulmonary Arterial Hypertension · Phase NA · Oct 2024
See all terminations from Assistance Publique - Hôpitaux de Paris
A PHASE3 clinical study on Gastroenteritis and Vomiting, this trial is terminated or withdrawn. The trial is conducted by Assistance Publique - Hôpitaux de Paris and has accumulated 5 data snapshots since 2014. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.
Status Flow
Change History
5 versions recorded-
Sep 2024 — Present [monthly]
Terminated PHASE3
-
Jul 2024 — Sep 2024 [monthly]
Terminated PHASE3
-
Jan 2021 — Jul 2024 [monthly]
Terminated PHASE3
-
Jun 2018 — Jan 2021 [monthly]
Terminated PHASE3
-
Jan 2017 — Jun 2018 [monthly]
Terminated PHASE3
First recorded
Jan 2014
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Assistance Publique - Hôpitaux de Paris
For direct contact, visit the study record on ClinicalTrials.gov .